StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

CNBX Pharmaceuticals's pe ratio was 379.0× on Mar 31, 2020.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Mar 31, 2020379.0×−355.5
2019Dec 31, 2019734.4×–

More CNBX Pharmaceuticals figures

See a number that looks wrong?